Name
Lecture: Bispecific Targeting of EGFR and UPAR in Canine Hemangiosarcoma
Date & Time
Tuesday, April 30, 2019, 9:45 AM - 10:45 AM
Speakers
Description
• Understand what Bispecific Ligand Targeted Toxins are and how they work in cancer therapy.
• Understand the rationale for targeting EGFR and uPAR in canine hemangiosarcoma as a therapeutic strategy using adjuvant eBAT, a bispecific EGF angiotoxin.
• Describe the clinical application of eBAT and understand how it differs from other EGFR targeting agents.